Deep Branch has appointed Kaspar Kristiansen as its new CEO, taking the reins from co-founder Peter Rowe, who will now focus on commercial development activities
A multidisciplinary team of scientists has been granted £1.5 million to develop an oral vaccine aimed at combating the issue of sea lice in farmed Atlantic salmon
We use cookies for performance, security and analytics.
To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.